Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|January 13, 2026
A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosisSamsher Singh, Pearly Shuyi Ng, Umayal Lakshmanan, et al.
Cell Death & Disease|January 13, 2023
SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasmZhan Yang, Ya-Xuan Wang, Jin-Kun Wen, et al.
China CDC Weekly|July 11, 2022
Case Fatality Rate of Patients with Acute Myocardial Infarction in 253 Chest Pain Centers - China, 2019-2020Zheng Long, Wei Liu, Zhenping Zhao, et al.
Nature Communications|December 1, 2020
Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosisJared S Mackenzie, Dirk A Lamprecht, Rukaya Asmal, et al.
IEEE Transactions on Neural Networks and Learning Systems|November 4, 2020
Supervised Learning Achieves Human-Level Performance in MOBA Games: A Case Study of Honor of KingsDeheng Ye, Guibin Chen, Peilin Zhao, et al.
Cell Death and Differentiation|October 16, 2023
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNAYong Zhang, Xiao-Nan Chen, Hong Zhang, et al.
Journal of Geriatric Cardiology : JGC|September 21, 2020
Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trialXiao-Si Jiang, Li-Chao Tian, Zi-Chao Jiang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2021
CDK13 upregulation-induced formation of the positive feedback loop among circCDK13, miR-212-5p/miR-449a and E2F5 contributes to prostate carcinogenesisJin-Chun Qi, Zhan Yang, Tao Lin, et al.
Journal of the American Heart Association|March 13, 2026
Clinical Validation of a Novel Pressure Microcatheter-Based Nonhyperemic Pressure Ratio (SUPREME II Study)Jinying Zhou, Junqing Yang, Wei Zhang, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 8, 2018
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trialTaku Asano, Qinhua Jin, Yuki Katagiri, et al.
Pageof 19